Addressing The Acetonitrile Supply By Implementing Recovery And Reuse Strategies

By Olivier Dapremont, Ph.D., Executive Director, Technology and Innovation

The growing demand for high‑grade acetonitrile (ACN), driven by increased production of peptides and oligonucleotides, is expected to significantly exceed global supply capacity in the coming years. This imbalance poses serious risks to pharmaceutical manufacturing, including rising costs, limited availability, and disrupted supply chains. To address these challenges, innovative strategies focused on solvent recovery and reuse are being explored as sustainable alternatives to reliance on newly produced ACN. These approaches aim to reduce waste, lower procurement costs, and improve supply security while maintaining the strict purity requirements necessary for advanced synthesis and analytical applications. However, implementing such solutions requires overcoming key challenges related to feasibility, economic viability, and regulatory approval.

Recent advancements in integrated recovery technologies demonstrate promising potential to produce high‑quality ACN efficiently, supporting both environmental sustainability and operational resilience within the pharmaceutical industry.